Skip to content
Search

Latest Stories

Paul Adams appointed as new CEO of LloydsPharmacy Clinical Homecare

Paul Adams appointed as new CEO of LloydsPharmacy Clinical Homecare

Adams is committed to creating healthcare systems that are both efficient and empathetic

LloydsPharmacy Clinical Homecare, a leading provider of home healthcare services in the UK, on Monday announced the appointment of Paul Adams as the company’s new Chief Executive Officer (CEO).


Before assuming his role at LPCH at the end of last year, Adams was leading transformation efforts at DD Group, formerly known as Dental Directory.

With a career spanning over two decades, Adams has held influential positions at Diageo, Smith+Nephew, and served as a CEO for various Private Equity companies. He has also co-authored “The Little Black Book of Change.”

Adams will lead the LPCH’s mission to pioneer the delivery of specialist clinical treatment therapies to patients, thereby enhancing patient outcomes within homecare and community settings while improving accessibility.

Adams said: "It’s a privilege to step into a role that has such a profound impact on the way healthcare is delivered.

"Our aim is to ensure that every patient has access to the vital healthcare they need, right in their own communities or homes, not only easing the load on the NHS but improving healthcare outcomes.”

LloydsPharmacy Clinical Homecare provides a comprehensive range of healthcare services, including specialist cancer care, clinical homecare, remote nursing, and community-based solutions.

Adams' leadership is expected to help the organisation further innovate its service delivery model, ensuring healthcare is even more responsive to the to the diverse needs of patients nationwide.

Adams strongly supports harnessing new digital-enabled capabilities to streamline the entire patient journey during their treatment, creating seamless interactions with both hospitals and private medical services.

"The adoption of digital solutions within the healthcare environment itself presents a major challenge, but this is something we are keen to do more of, given its importance in modernising healthcare services," Adams said.

Driven by a passion for creating healthcare systems that are both efficient and empathetic, Adams aims to infuse LloydsPharmacy Clinical Homecare with a culture of innovation, operational excellence, and a relentless focus on patient care.

"Healthcare must evolve to meet the changing demands of our society. I am committed to leading the organisation in a way that not only meets those demands but anticipates and addresses future healthcare needs,” he said.

“Demand for homecare services will only grow, and the services we offer are vital. They play a part in the country’s fabric of healthcare, and they can’t be replaced easily,” he added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less